Skip to main content

About us
- - - About us
      
      Compass Pathways is a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health.
  - - About us
    - Our team
      - Executive Team
      - Board of Directors
  - - Our stories
      
      Everyone has a story about how mental health has affected them or someone they know. Our people bring their stories, and a wide range of backgrounds and skills, to Compass.
      
      Read our stories
Our work
- - - Our work
      
      We want to give people living with mental health challenges better options.
  - - Our blog
      
      Read our blog to learn more about Compass and our work.
      
      Read more
Join us
- - - Join us
      
      We are united by our commitment to improving mental health.
  - - Join us
  - - Our purpose
      
      Watch our purpose video to find out who we are and what defines us.
      
      Find out more about our purpose
News and views
- - - News and views
      
      Our collective understanding of mental illness is increasing all the time, with advances in neuroscience, psychotherapy, psychopharmacology and digital platforms.
  - - Press releases
    - Our blog
  - - Our blog
      
      Read our blog to learn more about Compass and our work.
      
      Read more
Investors
- - - Investors
      
      We are Compass Pathways, a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health.
  - - Governance
    - Resources
  - - COMP360 psilocybin treatment in TRD
      
      We have completed the largest randomised, controlled, double-blind psilocybin treatment study ever done.
      
      Read more about COMP360 psilocybin treatment in TRD
Impact
- - - Impact
      
      We are working to create positive impact by developing transformative therapies for those who are not helped by current treatments, by helping to build the mental health ecosystem of the future, and by acting responsibly as an organisation.
  - - Impact
  - - About us
      
      Compass Pathways is a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health.
      
      Read more about us
LinkedIn
Youtube
Twitter
Accessibility

High Contrast
Greyscale
Negative Contrast
Readable
Reset

Search for news

Contact us

Our blog

Home
News and views
Our blog

For media inquiries, contact us at media@compasspathways.com

Looking for news? Read our investors news releases.

July 31, 2024

Compass’s hiking club

Read article
July 08, 2024

Joining a mission-driven team: talking to Lori Englebert, Compass’s new Chief Commercial Officer

Read article
May 20, 2024

Recognising Quality at Compass

Read article
May 20, 2024

Celebrating Clinical Trials Day with Mike Gold, Compass’s new Chief Research & Development Of...

Read article
May 16, 2024

Advancing Digital Accessibility

Read article
May 14, 2024

Supporting our team’s wellbeing

Read article
March 18, 2024

Recognising and celebrating neurodiversity

Read article
February 28, 2024

Exploring cultural consciousness with Jarell Bempong

Read article
June 01, 2023

Celebrating Pride 2023

Read article
April 06, 2023

Talking to a Principal Investigator on our Phase 3 programme

Read article
March 08, 2023

Launching our Diversity Equity and Inclusion (DEI) council

Read article
February 16, 2023

Compass’s impact strategy

Read article

Looking for news?

Read our press releases

This website is powered by renewable energy

Useful links

Contact us
About psilocybin therapy
About us
Join us
News and views

Follow us

LinkedIn
Youtube
Twitter

Sign up

Subscribe to receive the latest Compass news.

Subscribe

Unsolicited Information Policy
Terms
Privacy
myPathfinder privacy

Compass © 2024. All rights reserved. Made by GIG.

The press releases and articles contained in this section are provided for historical purposes only. The information contained in each press release and article is accurate only as of the date each press release and article was originally issued. Compass disavows any obligation to update the information contained in such press releases and articles after the date of their issuance.

You are now leaving Compass Pathways’ website.

Compass does not control and is not responsible for the content on the website you are about to visit. Compass is providing this link as a convenience, and this link does not imply Compass endorsement of any material on the website you are about to visit. Do you wish to continue?